5T5U

Crystal structure of Aspergillus fumigatus N-myristoyl transferase in complex with myristoyl CoA and a methylpyridyl-dipihenyl-pyridine ligand

5T5U の概要

• エントリーDOI: 10.2210/pdb5t5u/pdb
• 分子名称: Glycylpeptide N-tetradecanoyltransferase, TETRADECANOYL-COA, 2-methyl-3-({[3'-(piperidin-4-yl)[1,1'-biphenyl]-4-yl]oxy}methyl)pyridine, ... (4 entities in total)
• 機能のキーワード: acyltransferase, transferase, drug discovery
• 由来する生物種: Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100)
• 細胞内の位置: Cytoplasm: Q9UVX3
• タンパク質・核酸の鎖数: 1
• 化学式量合計: 48779.62

構造登録者

Robinson, D.A.,Wyatt, P.G. (登録日: 2016-08-31, 公開日: 2017-09-13, 最終更新日: 2024-01-17)

主引用文献

Bayliss, T.,Robinson, D.A.,Smith, V.C.,Brand, S.,McElroy, S.P.,Torrie, L.S.,Mpamhanga, C.,Norval, S.,Stojanovski, L.,Brenk, R.,Frearson, J.A.,Read, K.D.,Gilbert, I.H.,Wyatt, P.G.
Design and Synthesis of Brain Penetrant Trypanocidal N-Myristoyltransferase Inhibitors.
J. Med. Chem., 60:9790-9806, 2017

PubMed Abstract: N-Myristoyltransferase (NMT) represents a promising drug target within the parasitic protozoa Trypanosoma brucei (T. brucei), the causative agent for human African trypanosomiasis (HAT) or sleeping sickness. We have previously validated T. brucei NMT as a promising druggable target for the treatment of HAT in both stages 1 and 2 of the disease. We report on the use of the previously reported DDD85646 (1) as a starting point for the design of a class of potent, brain penetrant inhibitors of T. brucei NMT.

PubMed: 29125744
DOI: 10.1021/acs.jmedchem.7b01255

実験手法

X-RAY DIFFRACTION (1.8 Å)